| Autor: |
Putniković D; Institute of Pathology 'Prof. dr Đorđe Joannović', Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia., Jevtić J; Institute of Pathology 'Prof. dr Đorđe Joannović', Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia., Ristić N; Department of Gastroenterology, University's Children's Hospital, 11000 Belgrade, Serbia., Milovanovich ID; Department of Gastroenterology, University's Children's Hospital, 11000 Belgrade, Serbia.; Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia., Đuknić M; Institute of Pathology 'Prof. dr Đorđe Joannović', Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia., Radusinović M; Department of Gastroenterology, University's Children's Hospital, 11000 Belgrade, Serbia., Popovac N; Department of Gastroenterology, University's Children's Hospital, 11000 Belgrade, Serbia., Đorđić I; Department of Gastroenterology, University's Children's Hospital, 11000 Belgrade, Serbia., Leković Z; Department of Gastroenterology, University's Children's Hospital, 11000 Belgrade, Serbia.; Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia., Janković R; Institute of Pathology 'Prof. dr Đorđe Joannović', Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia. |
| Abstrakt: |
Crohn's disease (CD) is a progressive, multifactorial, immune-mediated disease characterized by chronic inflammation of any part of the gastrointestinal (GI) tract. Pediatric patients present with a more extensive form of the disease, especially in the upper GI tract with various histopathological inflammatory patterns. Our study aims to analyze the clinical, laboratory, endoscopic, and histopathological findings in children with diagnosed CD and compare results on the initial and follow-up tests. We have included 100 children and adolescents with CD, with performed endoscopic and histopathological (HP) procedures. The results of multiple biopsies executed in these 8 years were matched and compared. We found a statistically significant frequency reduction in stool changes (65.52% to 18.18%), weight loss (35.24% to 4%), and abdominal pain (41.86% to 6.67%) as presenting symptoms. There was an improvement in all laboratory values: fecal calprotectin (1000 to 60,8 μg/g), C-reactive protein (12.2 to 1.9 mg/L), and albumin (36 to 41 g/L). On esophagogastroduodenoscopy and ileo-colonoscopy 36.59% and 64.86% patients had specific findings, respectively. A total of 32 patients had evidence of Crohn's disease in the upper GI tract. Non-caseating granulomas were found on 9% of oesophageal, 18% of gastric, and 12% of duodenal biopsies. In the lower GI tract, we have observed a disease progression in the rectum (72.29 to 82.22%) and descending colon (73.49 to 80%). There was no registered disease progression in the upper GI tract. Our study demonstrated a significant decline in the frequency of symptoms and an improvement in laboratory values on the follow-up examinations. More than a third of our patients had specific endoscopic and HP findings in the upper GI tract, and an additional 23% had HP findings highly suggestive of CD. We demonstrated the importance of regular clinical, laboratory, endoscopic, and histopathological assessments of pediatric CD patients. |
